نتایج جستجو برای: piperacillin

تعداد نتایج: 2563  

Journal: :The Journal of antimicrobial chemotherapy 2008
K Orlopp M von Lilienfeld-Toal G Marklein S M Reiffert A Welter C Hahn-Ast I Purr M Gorschlüter E Molitor A Glasmacher

OBJECTIVES False-positive results of the galactomannan (GM) ELISA caused by concurrent administration of piperacillin/tazobactam have been reported in patients with febrile neutropenia. PATIENTS AND METHODS This prospective study investigated different sampling times in 30 patients receiving piperacillin/tazobactam for febrile neutropenia. RESULTS Prior to the first piperacillin/tazobactam ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2007
Giulia Ghibellini Arlene S Bridges Claudia N Generaux Kim L R Brouwer

Piperacillin metabolism and biliary excretion are different between humans and preclinical species. In the present study, piperacillin metabolites were characterized in bile and urine of healthy humans and compared with metabolites formed in vitro. Volunteers were administered 2 g of piperacillin IV; blood, urine, and duodenal aspirates (obtained via a custom-made oroenteric catheter) were coll...

Journal: :Antimicrobial agents and chemotherapy 1986
R V McCloskey

The objective of this double-blind study was to compare the efficacy and safety of piperacillin with that of cefoxitin in patients with bacterial infections. Seventy hospitalized patients were treated with intravenous piperacillin (18 g/day) or cefoxitin (12 g/day) for a mean period of 11.5 days. Multiple serious underlying conditions were present in 91% of the patients in both treatment groups...

2014
Dawood Yusef Blanca E Gonzalez Charles B Foster Johanna Goldfarb Carla Saracusa Sarah Worley Camille Sabella

Background. Piperacillin/tazobactam is an ureidopenicillin (piperacillin) combined with a ß-lactamase inhibitor (tazobactam). We have noted an increased rate of suspected piperacillin/tazobactam-related adverse drug events (ADEs) compared to other antibiotics in patients on Outpatient Parenteral Antimicrobial Therapy (OPAT). We sought to compare ADEs in patients who received piperacillin/tazoba...

Journal: :Antimicrobial agents and chemotherapy 2005
Mark J DiNubile Joseph W Chow Vilas Satishchandran Adam Polis Mary R Motyl Murray A Abramson Hedy Teppler

Bowel colonization with resistant bacteria can develop in patients receiving broad-spectrum antimicrobial therapy. We compared the impact of two antimicrobial regimens often used to treat intraabdominal infections on susceptibility patterns of bowel flora at the end of therapy. In a double-blind clinical trial, adults with complicated intraabdominal infection requiring surgery were randomized t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید